New treatment options for non-alcoholic fatty liver disease

(Johannes Gutenberg Universitaet Mainz) Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent liver diseases worldwide and an estimated 20 million people in Germany are affected. The aim of the joint research initiative that has been developed in cooperation of the Mainz University Medical Center, Johannes Gutenberg University Mainz (JGU), and Goethe University Frankfurt is to employ a novel and applicable lifestyle intervention that is feasible and exerts a lasting benefit.